+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
ROSSARI

Rossari Biotech Share Price

₹437.15 +3.85 (0.89%)
36.67% Fall from 52W High

15 Oct, 2026 3:31 PM (IST)

Rossari Biotech live price: ₹437.15. It opened at ₹435 vs previous close ₹433; intraday high/low: ₹443/₹424. The 50 & 200 DMA stand at ₹456.70/₹509.50.

Rossari Biotech Performance

  • Today's Low
  • ₹424
  • Today's High
  • ₹443
  • 52 Week Low
  • ₹375
  • 52 Week High
  • ₹690
  • Open Price₹435
  • Previous Close₹433
  • Volume64,726
  • 50 DMA₹456.70
  • 100 DMA₹477.80
  • 200 DMA₹509.50

Rossari Biotech Chart

Investment Returns

  • Over 1 Month -2.02%
  • Over 3 Month -17.12%
  • Over 6 Month -1.64%
  • Over 1 Year -32.42%

Smart Investing Starts Here Start SIP with Rossari Biotech for Steady Growth!

Invest Now

Rossari Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 16.1
  • PEG Ratio
  • 1.4
  • Market Cap Cr
  • 2,422
  • P/B Ratio
  • 1.8
  • Average True Range
  • 15.3
  • EPS
  • 27.2
  • Dividend Yield
  • 0.1
  • MACD Signal
  • -10
  • RSI
  • 48.16
  • MFI
  • 61.04

Latest Stock News Updates

Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Intimation of Earnings Conference Call for investor and analyst on Monday, October 19, 2026 at 04:00 P.M. (IST).

Rossari Biotech Ltd - 543213 - Board Meeting Intimation for Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Half Year Ended September 30, 2026.

Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/10/2026 ,inter alia, to consider and approve Unaudited Financial Results (Standalone & Consolidated) for the quarter and half year ended September 30, 2026.

Rossari Biotech Ltd - 543213 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026

Rossari Biotech Financials

Rossari Biotech Technicals

EMA & SMA

Current Price
₹437.15
+ 3.85 (0.89%)
pointer
  • Bearish Moving Average 9
  • Bullish Moving Average 7
  • 20 Day
  • ₹434.40
  • 50 Day
  • ₹456.70
  • 100 Day
  • ₹477.80
  • 200 Day
  • ₹509.50

Resistance and Support

434.55 Pivot Speed
  • R3 463.60
  • R2 453.00
  • R1 445.10
  • S1 426.60
  • S2 416.00
  • S3 408.10

Rossari Biotech Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-10-17 Quarterly Results
2026-07-18 Quarterly Results
2026-04-27 Audited Results & Final Dividend
2026-01-17 Quarterly Results
2025-10-15 Quarterly Results
Date Purpose Remarks
2026-07-10 FINAL Rs.0.50 per share(25%)Final Dividend
2025-06-20 FINAL Rs.0.50 per share(25%)Final Dividend
View Rossari Biotech Dividend History Arrow

Rossari Biotech Shareholding Pattern

68.14%
15.84%
9.11%
5.08%
1.84%

About Rossari Biotech

Rossari Biotech is mainly engaged in manufacturing, selling and distribution of specialty chemicals. The products cater to global brands in the FMCG sector and find applications in a host of consumer-centric products and home and personal care products, textile chemicals, animal health and nutrition and cosmetic products. View More
  • NSE Symbol
  • ROSSARI
  • BSE Symbol
  • 543213
  • ISIN
  • INE02A801020

Similar Stocks to Rossari Biotech

Rossari Biotech FAQs

Rossari Biotech share price is ₹437 As on 16 October, 2026 | 06:14

The Market Cap of Rossari Biotech is ₹2421.6 Cr As on 16 October, 2026 | 06:14

The P/E ratio of Rossari Biotech is 16.1 As on 16 October, 2026 | 06:14

The PB ratio of Rossari Biotech is 1.8 As on 16 October, 2026 | 06:14

The 52 week High & Low of Rossari Biotech is ₹690.3/₹375 respectively As on 16 October, 2026 | 06:14

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23